Latest news with #MajaPataki
Business Insider
4 days ago
- Business
- Business Insider
Kepler Capital Reaffirms Their Buy Rating on Straumann Holding AG (STMN)
Kepler Capital analyst Maja Pataki maintained a Buy rating on Straumann Holding AG on August 13 and set a price target of CHF150.00. The company's shares closed yesterday at CHF93.64. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Pataki covers the Healthcare sector, focusing on stocks such as Demant, DiaSorin S.p.A., and Alcon. According to TipRanks, Pataki has an average return of -13.4% and a 33.33% success rate on recommended stocks. In addition to Kepler Capital , Straumann Holding AG also received a Buy from Barclays's Hassan Al-Wakeel in a report issued yesterday. However, on the same day, Citi maintained a Sell rating on Straumann Holding AG (Six Swiss: STMN).
Business Insider
4 days ago
- Business
- Business Insider
Kepler Capital Reaffirms Their Buy Rating on Demant (WILLF)
In a report released on August 13, Maja Pataki from Kepler Capital maintained a Buy rating on Demant, with a price target of DKK315.00. The company's shares closed yesterday at $38.14. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Pataki covers the Healthcare sector, focusing on stocks such as Demant, DiaSorin S.p.A., and Alcon. According to TipRanks, Pataki has an average return of -13.4% and a 33.33% success rate on recommended stocks. Demant has an analyst consensus of Strong Buy, with a price target consensus of $48.13, which is a 26.19% upside from current levels. In a report released yesterday, J.P. Morgan also maintained a Buy rating on the stock with a DKK291.00 price target.
Business Insider
5 days ago
- Business
- Business Insider
Kepler Capital Sticks to Their Hold Rating for Tecan Group AG (TCHBF)
In a report released on August 12, Maja Pataki from Kepler Capital maintained a Hold rating on Tecan Group AG, with a price target of CHF180.00. The company's shares closed last Wednesday at $211.90. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Pataki covers the Healthcare sector, focusing on stocks such as DiaSorin S.p.A., Alcon, and Demant. According to TipRanks, Pataki has an average return of -13.4% and a 33.33% success rate on recommended stocks. Tecan Group AG has an analyst consensus of Hold, with a price target consensus of $227.05, implying a 7.15% upside from current levels. In a report released yesterday, Morgan Stanley also maintained a Hold rating on the stock with a CHF168.00 price target. Based on Tecan Group AG's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $467.12 million and a net profit of $45.2 million. In comparison, last year the company earned a revenue of $532.89 million and had a net profit of $78.88 million
Business Insider
10-08-2025
- Business
- Business Insider
Galenica AG (GALE) Gets a Hold from Kepler Capital
In a report released on August 8, Maja Pataki from Kepler Capital maintained a Hold rating on Galenica AG, with a price target of CHF89.00. The company's shares closed last Friday at CHF84.35. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Pataki covers the Healthcare sector, focusing on stocks such as DiaSorin S.p.A., Demant, and Alcon. According to TipRanks, Pataki has an average return of -13.3% and a 33.74% success rate on recommended stocks. Galenica AG has an analyst consensus of Hold, with a price target consensus of CHF84.33, which is a -0.02% downside from current levels. In a report released on August 8, UBS also maintained a Hold rating on the stock with a CHF86.00 price target. The company has a one-year high of CHF90.15 and a one-year low of CHF71.55. Currently, Galenica AG has an average volume of 85.17K.
Business Insider
29-06-2025
- Business
- Business Insider
Kepler Capital Sticks to Its Hold Rating for Coloplast A/S (0QBO)
Kepler Capital analyst Maja Pataki maintained a Hold rating on Coloplast A/S (0QBO – Research Report) on June 27 and set a price target of DKK715.00. The company's shares closed last Friday at DKK604.61. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Pataki is an analyst with an average return of -13.5% and a 34.17% success rate. Pataki covers the Healthcare sector, focusing on stocks such as DiaSorin S.p.A., Coloplast A/S, and Demant. Currently, the analyst consensus on Coloplast A/S is a Hold with an average price target of DKK687.30.
